Karah Herdman Parschauer Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Karah Herdman Parschauer.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Karah Herdman Parschauer. Karah Herdman Parschauer is EVP and General Counsel in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Evolus, Inc. ($EOLS) and Director in Arcturus Therapeutics Holdings Inc. ($ARCT).

Latest Insider Trading Transactions of Karah Herdman Parschauer

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ARCT, EOLS, RARE

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 10 2021	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	113.67	313	35,579	29,997	30.3 K to 30 K (-1.03 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	A	142.47	11,000	1,567,170	11,000
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	138.17	3,970	548,535	30,227	34.2 K to 30.2 K (-11.61 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	4,636	0	34,197	29.6 K to 34.2 K (+15.68 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	5,500	0	29,561	24.1 K to 29.6 K (+22.86 %)
Feb 09 2021	EOLS	Evolus, Inc.	Parschauer Karah Herdman	Director	Grant	A	0.00	19,313	0	19,313	0 to 19.3 K
Nov 02 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	54.50	9,903	539,714	25,000
Nov 02 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	100.12	9,903	991,488	24,061	34 K to 24.1 K (-29.16 %)
Nov 02 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	54.50	9,903	539,714	33,871	24 K to 33.9 K (+41.32 %)
Oct 30 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	54.50	97	5,287	34,903
Oct 30 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	100.00	97	9,700	23,968	24.1 K to 24 K (-0.40 %)
Oct 30 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	54.50	97	5,287	24,065	24 K to 24.1 K (+0.40 %)
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	88.00	325	28,600	23,968	24.3 K to 24 K (-1.34 %)
Oct 13 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	54.50	10,000	545,000	35,000
Oct 13 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	95.00	10,000	950,000	24,293	34.3 K to 24.3 K (-29.16 %)
Oct 13 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	54.50	10,000	545,000	34,293	24.3 K to 34.3 K (+41.16 %)
Oct 07 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	48.43	10,000	484,300	17,000
Oct 07 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	90.00	10,000	900,000	24,293	34.3 K to 24.3 K (-29.16 %)
Oct 07 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	48.43	10,000	484,300	34,293	24.3 K to 34.3 K (+41.16 %)
Sep 24 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	48.43	10,000	484,300	27,000
Sep 24 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	85.00	10,000	850,000	24,293	34.3 K to 24.3 K (-29.16 %)
Sep 24 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	48.43	10,000	484,300	34,293	24.3 K to 34.3 K (+41.16 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	54.50	10,000	545,000	45,000
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	88.39	2,370	209,484	24,293	26.7 K to 24.3 K (-8.89 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	88.44	10,000	884,400	26,663	36.7 K to 26.7 K (-27.28 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	54.50	10,000	545,000	36,663	26.7 K to 36.7 K (+37.51 %)
Jun 24 2020	ARCT	Arcturus Therapeut ...	Parschauer Karah Herdman	Director	Option Exercise	A	40.70	15,000	610,500	15,000
Jun 22 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	78.22	649	50,765	26,663	27.3 K to 26.7 K (-2.38 %)
May 19 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	74.72	2,722	203,374	27,312	30 K to 27.3 K (-9.06 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	66.26	248	16,432	29,904	30.2 K to 29.9 K (-0.82 %)
Apr 21 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	58.57	248	14,525	30,152	30.4 K to 30.2 K (-0.82 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	A	56.08	22,000	1,233,760	22,000
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	56.08	2,118	118,777	30,400	32.5 K to 30.4 K (-6.51 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	5,634	0	32,518	26.9 K to 32.5 K (+20.96 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	7,800	0	26,884	19.1 K to 26.9 K (+40.87 %)
Jan 24 2020	EOLS	Evolus, Inc.	Parschauer Karah Herdman	Director	Option Exercise	A	10.19	23,458	239,037	23,458
Oct 29 2019	ARCT	Arcturus Therapeut ...	Parschauer Karah Herdman	Director	Option Exercise	A	10.23	20,000	204,600	20,000
Oct 29 2019	ARCT	Arcturus Therapeut ...	Parschauer Karah Herdman	Director	Option Exercise	A	10.23	15,000	153,450	15,000
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	1,434	0	19,084	17.7 K to 19.1 K (+8.12 %)
Jul 17 2019	EOLS	Evolus, Inc.	Parschauer Karah Herdman	Director	Option Exercise	A	15.99	26,163	418,346	26,163
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	61.50	1,226	75,399	17,650	18.9 K to 17.7 K (-6.50 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	63.01	1,489	93,822	18,876	20.4 K to 18.9 K (-7.31 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	63.48	649	41,199	20,365	21 K to 20.4 K (-3.09 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	61.50	1,226	75,399	17,650	18.9 K to 17.7 K (-6.50 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	63.01	1,489	93,822	18,876	20.4 K to 18.9 K (-7.31 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	63.48	649	41,199	20,365	21 K to 20.4 K (-3.09 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	1,434	0	21,014	19.6 K to 21 K (+7.32 %)
Apr 30 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	68.30	468	31,964	19,580	20 K to 19.6 K (-2.33 %)
Apr 23 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	64.43	248	15,979	20,048	20.3 K to 20 K (-1.22 %)
Aug 21 2018	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	78.53	5,000	392,650	9,181	14.2 K to 9.2 K (-35.26 %)
Jun 21 2018	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	82.77	1,226	101,476	14,181	15.4 K to 14.2 K (-7.96 %)
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	85.31	649	55,366	15,407	16.1 K to 15.4 K (-4.04 %)
May 10 2018	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	60.00	1,465	87,900	16,056	17.5 K to 16.1 K (-8.36 %)
Apr 19 2018	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	1,431	0	17,521	16.1 K to 17.5 K (+8.89 %)
Jun 21 2017	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	63.38	705	44,683	8,795	9.5 K to 8.8 K (-7.42 %)
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	A	88.80	12,000	1,065,600	12,000
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	2,000	0	9,500	7.5 K to 9.5 K (+26.67 %)
Jun 22 2016	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	A	54.50	60,000	3,270,000	60,000
Jun 22 2016	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	7,500	0	7,500	0 to 7.5 K

Page: 1